Jun Peng

Jun Peng

Auto-generated profile, based on publicly available information

Jun Peng

Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2010 in Stem Cells
Verified
Journal Article
Open access
PDF file
ASAndrzej Swistowski
Andrzej Swistowski
JPJun Peng
Jun Peng
QLQiuyue Liu
Qiuyue Liu
PMPrashant Mali
Prashant Mali
MRMahendra S. Rao
Mahendra S. Rao
XZXianmin Zeng
Xianmin Zeng
Human induced pluripotent stem cells (iPSCs) reprogrammed from somatic cells represent a promising unlimited cell source for generating patient-specific cells for biomedical research and personalized medicine. As a first step, critical to clinical applications, we attempted to develop defined culture conditions to expand and differentiate human iPSCs into functional progeny such as dopaminergic neurons for treating or modeling Parkinson's disease (PD). We used a completely defined (xeno-free) system that we previously developed for efficient generation of authentic dopaminergic neurons from human embryonic stem cells (hESCs), and applied it to iPSCs. First, we adapted two human iPSC lines derived from different somatic cell types for the defined expansion medium and showed that the iPSCs grew similarly as hESCs in the same medium regarding pluripotency and genomic stability. Second, by using these two independent adapted iPSC lines, we showed that the process of differentiation into committed neural stem cells (NSCs) and subsequently into dopaminergic neurons was also similar to hESCs. Importantly, iPSC-derived dopaminergic neurons were functional as they survived and improved behavioral deficits in 6-hydroxydopamine-leasioned rats after transplantation. In addition, iPSC-derived NSCs and neurons could be efficiently transduced by a baculoviral vector delivering episomal DNA for future gene function study and disease modeling using iPSCs. We also performed genome-wide microarray comparisons between iPSCs and hESCs, and we derived NSC and dopaminergic neurons. Our data revealed overall similarity and visible differences at a molecular level. Efficient generation of functional dopaminergic neurons under defined conditions will facilitate research and applications using PD patient-specific iPSCs.

18 July 2022 in Frontiers in Neurology
Verified
Journal Article
Open access
YHYue Hu
Yue Hu
PCPu Cai
Pu Cai
HZHuawei Zhang
Huawei Zhang
AAAihemaitiniyazi Adilijiang
Aihemaitiniyazi Adilijiang
JPJun Peng
Jun Peng
CLChangqing Liu
Changqing Liu
Introduction: Frame-based stereotactic biopsy is well-established to play an essential role in neurosurgery. In recent years, different robotic devices have been introduced in neurosurgery centers. This study aimed to compare the SINO surgical robot-assisted frameless brain biopsy with standard frame-based stereotactic biopsy in terms of efficacy, accuracy and complications.Methods: A retrospective analysis was performed on 151 consecutive patients who underwent stereotactic biopsy at Chongqing Sanbo Jiangling Hospital between August 2017 and December 2021. All patients were divided into the frame-based group (n = 47) and the SINO surgical robot-assisted group (n = 104). The data collected included clinical characteristics, diagnostic yield, operation times, accuracy, and postoperative complications.Results: There was no significant difference in diagnostic yield between the frame-based group and the SINO surgical robot-assisted group (95.74 vs. 98.08%, p > 0.05). The mean operation time in the SINO surgical robot-assisted group was significantly shorter than in the frame-based group (29.36 ± 13.64 vs. 50.57 ± 41.08 min). The entry point error in the frame-based group was significantly higher than in the robot-assisted group [1.33 ± 0.40 mm (0.47–2.30) vs. 0.92 ± 0.27 mm (0.35–1.65), P < 0.001]. The target point error in the frame-based group was also significantly higher than in the robot-assisted group [1.63 ± 0.41 mm (0.74–2.65) vs. 1.10 ± 0.30 mm (0.69–2.03), P < 0.001]. Finally, there was no significant difference in postoperative complications between the two groups.Conclusion: Robot-assisted brain biopsy becomes an increasingly mainstream tool in the neurosurgical procedure. The SINO surgical robot-assisted platform is as efficient, accurate and safe as standard frame-based stereotactic biopsy and provides a reasonable alternative to stereotactic biopsy in neurosurgery.

12 September 2022 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
JFJunqi Fu
Junqi Fu
JPJun Peng
Jun Peng
GTGuolong Tu
Guolong Tu
Glioma is a malignant tumor that often occurs in the adult central nervous system. Metadherin/astrocyte-elevated gene-1 (MTDH) is involved in the development of cancer, but its relationship with glioma remains unclear. This study is aimed at clarifying the role of MTDH in glioma. GEPIA was employed to find the difference of the expression level of MTDH and MYB protooncogene-like 2 (MYBL2) in glioma tissues and normal tissues, and real-time quantitative reverse transcription PCR (qRT-PCR) and western blot (WB) were applied to verify the differential gene expression of MTDH and MYBL2 cells. After knocking down of MTDH, the expressions of forkhead box M1 (FoxM1), MTDH, and MYBL2 were detected by WB cells. Cell counting kit 8 (CCK-8) was used to detect cell proliferation, and flow cytometry was applied to measure cell apoptosis. The transwell assay was utilized to investigate the ability of cell migration and invasion. The results showed that MTDH and MYBL2 were overexpressed in glioma cells compared with normal cells. The knockdown of MTDH would inhibit the expression of MYBL2 through decreasing the expression of FoxM1 and further reduce glioma cell proliferation and cell migration and invasion. The present study showed that knockdown of MTDH inhibits glioma proliferation and migration and promotes apoptosis by downregulating MYBL2, which suggests that MTDH is a potential gene in clinical treatment of glioma.

12 April 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
KQKai Qian
Kai Qian
YDYi Deng
Yi Deng
WKWilliam S. Krimsky
William S. Krimsky
YFYong-Geng Feng
Yong-Geng Feng
JPJun Peng
Jun Peng
LJLihong Jiang
Lihong Jiang
Microbes and microbiota dysbiosis are correlated with the development of lung cancer; however, the airway taxa characteristics and bacterial topography in synchronous multiple primary lung cancer (sMPLC) are not fully understood. The present study aimed to investigate the microbiota taxa distribution and characteristics in the airways of patients with sMPLC and clarify specimen acquisition modalities in these patients. Using the precise positioning of electromagnetic navigation bronchoscopy (ENB), we analyzed the characteristics of the respiratory microbiome, which were collected from different sites and using different sampling methods. Microbiome predictor variables were bacterial DNA burden and bacterial community composition based on 16sRNA. Eight non-smoking patients with sMPLC in the same pulmonary lobe were included in this study. Compared with other sampling methods, bacterial burden and diversity were higher in surface areas sampled by bronchoalveolar lavage (BAL). Bacterial topography data revealed that the segment with sMPLC lesions provided evidence of specific colonizing bacteria in segments with lesions. After taxonomic annotation, we identified 4863 phylotypes belonging to 185 genera and 10 different phyla. The four most abundant specific bacterial community members detected in the airway containing sMPLC lesions were Clostridium, Actinobacteria, Fusobacterium, and Rothia, which all peaked at the segments with sMPLC lesions. This study begins to define the bacterial topography of the respiratory tract in patients with sMPLC and provides an approach to specimen acquisition for sMPLC, namely BAL fluid obtained from segments where lesions are located.

5 July 2013 in Chinese Medical Journal
Verified
Journal Article
Open access
PQPing Qin
Ping Qin
JPJun Peng
Jun Peng
MHMing Hou
Ming Hou

1 January 2025 in Mediators of Inflammation
Verified
Journal Article
Open access
JPJun Peng
Jun Peng
XHXiqi Hu
Xiqi Hu
JHJun He
Jun He
YXYing Xia
Ying Xia
Background: Pyroptosis is implicated as a pathogenic mechanism in early brain injury (EBI) after subarachnoid hemorrhage (SAH). This study aimed to investigate the regulatory role of G protein‐coupled receptor 30 (GPR30) in neuronal pyroptosis during SAH. Methods: SAH was induced in rats via intravascular perforation and hemin‐treated neurons modeled SAH in vitro. GPR30 agonist G1 and antagonist G15 were administered to assess functional impacts. Neurological deficits (Garcia score), SAH severity, and cerebral edema (brain water content) were evaluated. Pyroptotic markers (cleaved caspase‐1, gasdermin D (GSDMD)‐N, interleukin (IL)‐1β, and IL‐18) were quantified. Inflammasome activation (NLRC4 and IFI16) and Toll‐like receptor 4/nuclear factor kappa‐B (TLR4/NF‐κB) signaling were analyzed via immunofluorescence (IF) and immunoblotting. The TLR4 antagonist LPS‐RS (lipopolysaccharide from Rhodobacter sphaeroides ) was applied to validate pathway involvement. Results: GPR30 expression increased post‐SAH. G15 exacerbated hemorrhage severity, neurological deficits, and cerebral edema, whereas G1 modestly attenuated SAH. G15 upregulated pyroptotic markers, enhanced neuronal pyroptosis, and activated NLRC4/IFI16 inflammasomes. Concurrently, G15 stimulated TLR4/MyD88 expression and NF‐κB phosphorylation. Conversely, G1 suppressed pyroptosis, inactivated inflammasomes, and inhibited TLR4/NF‐κB signaling. LPS‐RS cotreatment reversed G15‐induced pyroptotic and inflammatory cascades. Conclusion: GPR30 mitigates NLRC4‐ and IFI16‐driven neuronal pyroptosis in SAH by modulating TLR4/NF‐κB signaling. Pharmacological targeting of GPR30 represents a promising therapeutic strategy to ameliorate SAH‐associated brain injury.